olmesartan medoxomil (Cadila Healthcare Limited)
Welcome to the PulseAid listing for the olmesartan medoxomil drug offered from Cadila Healthcare Limited. This Angiotensin 2 Receptor Antagonists [MoA],Angiotensin 2 Receptor Blocker [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Cadila Healthcare Limited |
| NON-PROPRIETARY NAME: | olmesartan medoxomil |
| SUBSTANCE NAME: | OLMESARTAN MEDOXOMIL |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Angiotensin 2 Receptor Antagonists [MoA],Angiotensin 2 Receptor Blocker [EPC] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET, FILM COATED |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2017-04-24 |
| END MARKETING DATE: | 0000-00-00 |
olmesartan medoxomil HUMAN PRESCRIPTION DRUG Details:
| Item Description | olmesartan medoxomil from Cadila Healthcare Limited |
| LABELER NAME: | Cadila Healthcare Limited |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 5(mg/1) |
| START MARKETING DATE: | 2017-04-24 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 70771-1059_38017893-85e5-44b2-906e-87f78cd4dea0 |
| PRODUCT NDC: | 70771-1059 |
| APPLICATION NUMBER: | ANDA205192 |
Other OLMESARTAN MEDOXOMIL Pharmaceutical Manufacturers / Labelers:
